These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36073371)

  • 1. Promising antibacterials for LLM of
    Rathi R; Kumari R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023; 41(15):7277-7289. PubMed ID: 36073371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors for LLM of
    Kumari R; Dalal V
    J Biomol Struct Dyn; 2022; 40(20):9833-9847. PubMed ID: 34096457
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential inhibitors of FemC to combat
    Rathi R
    J Biomol Struct Dyn; 2023 Dec; 41(20):10495-10506. PubMed ID: 36524526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational investigation of potent inhibitors against YsxC: structure-based pharmacophore modeling, molecular docking, molecular dynamics, and binding free energy.
    Kumari R; Rathi R; Pathak SR; Dalal V
    J Biomol Struct Dyn; 2023 Feb; 41(3):930-941. PubMed ID: 34913841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA.
    Kumari R; Kumar V; Dhankhar P; Dalal V
    J Biomol Struct Dyn; 2023 Jul; 41(10):4650-4666. PubMed ID: 35510600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization and structure-based
    Gupta DN; Dalal V; Savita BK; Alam MS; Singh A; Gubyad M; Ghosh DK; Kumar P; Sharma AK
    J Biomol Struct Dyn; 2023; 41(12):5776-5788. PubMed ID: 35815556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico functional and structural annotation of hypothetical protein from Klebsiella pneumonia: A potential drug target.
    Singh V; Dhankhar P; Dalal V; Tomar S; Kumar P
    J Mol Graph Model; 2022 Nov; 116():108262. PubMed ID: 35839717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking, dynamics simulation and pharmacokinetic studies of
    Swain A; Choudhir G; Prabakaran D; Hariprasad P
    J Biomol Struct Dyn; 2023 Nov; 41(19):9245-9255. PubMed ID: 36373334
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Verma AK; Srivastava SK
    J Biomol Struct Dyn; 2024 Feb; ():1-21. PubMed ID: 38319034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM.
    Dalal V; Dhankhar P; Singh V; Singh V; Rakhaminov G; Golemi-Kotra D; Kumar P
    Protein J; 2021 Apr; 40(2):148-165. PubMed ID: 33421024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
    Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
    J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel natural MurD ligase inhibitors as potential antimicrobial agents targeting
    Tiwari P; Sharma P; Kumar M; Kapil A; Abdul Samath E; Kaur P
    J Biomol Struct Dyn; 2022; 40(24):14051-14066. PubMed ID: 34766874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into 5-lipoxygenase inhibition by pyocyanin: a molecular docking and molecular dynamics study.
    Santha SSR; Vishwanathan AS
    J Biomol Struct Dyn; 2022; 40(20):9752-9760. PubMed ID: 34143945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, dynamic docking, synthesis, and
    Pudipeddi A; Vasudevan S; Shanmugam K; Mohan S S; Vairaprakash P; Neelakantan P; Balraj AS; Solomon AP
    J Biomol Struct Dyn; 2023; 41(13):6345-6358. PubMed ID: 35924774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study.
    Alabbas AB
    Saudi Pharm J; 2023 Sep; 31(9):101745. PubMed ID: 37638221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Repurposing Approach To Combat
    Singh V; Dhankhar P; Dalal V; Tomar S; Golemi-Kotra D; Kumar P
    ACS Omega; 2022 Nov; 7(43):38448-38458. PubMed ID: 36340146
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus.
    Maki H; Murakami K
    J Bacteriol; 1997 Nov; 179(22):6944-8. PubMed ID: 9371438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of promising molecules against MurG as drug target in multi-drug-resistant-
    Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2020 Oct; 38(17):5230-5252. PubMed ID: 31787065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin-resistant
    Verma AK; Ahmed SF; Hossain MS; Bhojiya AA; Mathur A; Upadhyay SK; Srivastava AK; Vishvakarma NK; Barik M; Rahaman MM; Bahadur NM
    J Biomol Struct Dyn; 2022; 40(21):10561-10577. PubMed ID: 34243699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling of human BAP1 and analysis of its binding properties through molecular docking and molecular dynamics simulation.
    Husain S; Mohamed R; Abd Halim KB; Mohd Mutalip SS
    J Biomol Struct Dyn; 2023; 41(15):7158-7173. PubMed ID: 36039769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.